UK markets open in 1 hour 49 minutes
NIKKEI 225
31,227.80 -532.08 (-1.68%) HANG SENG
17,278.37 -531.29 (-2.98%) CRUDE OIL
88.13 -0.69 (-0.78%) GOLD FUTURES
1,836.30 -10.90 (-0.59%) DOW
33,433.35 -74.15 (-0.22%) Bitcoin GBP
22,874.69 -382.15 (-1.64%)
Sutro Biopharma, Inc. (STRO)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.4700 |
| Open | 3.4900 |
| Bid | 0.0000 x 800 |
| Ask | 0.0000 x 1800 |
| Day's range | 3.3800 - 3.6000 |
| 52-week range | 3.2400 - 8.7200 |
| Volume | |
| Avg. volume | 292,387 |
| Market cap | 211.844M |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.3800 |
| Earnings date | 06 Nov 2023 - 10 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 17.75 |
ZacksSutro Biopharma, Inc. (STRO) Reports Q2 Loss, Lags Revenue Estimates
Sutro Biopharma, Inc. (STRO) delivered earnings and revenue surprises of 12.33% and 0.33%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksAll You Need to Know About Sutro Biopharma, Inc. (STRO) Rating Upgrade to Buy
Sutro Biopharma, Inc. (STRO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ZacksStoke Therapeutics, Inc. (STOK) Surges 6.3%: Is This an Indication of Further Gains?
Stoke Therapeutics, Inc. (STOK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
© 2023 Yahoo. All rights reserved.
